UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 277

Sortiert nach

Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant

Cardiovascular drugs and therapy, 2022-02, Vol.36 (1), p.121-129

2022

Volltextzugriff (PDF)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

Cardiovascular drugs and therapy, 2021-12, Vol.35 (6), p.1183-1190

2021

Volltextzugriff (PDF)

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials

Cardiovascular drugs and therapy, 2013-04, Vol.27 (2), p.171-179

2013

Volltextzugriff (PDF)

Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture

Cardiovascular drugs and therapy, 2017-04, Vol.31 (2), p.145-156

2017

Volltextzugriff (PDF)

Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease

Cardiovascular drugs and therapy, 2009-02, Vol.23 (1), p.93-101

Rosenson, Robert S.

2009

Volltextzugriff (PDF)

Renin-Angiotensin System Phenotyping as a Guidance Toward Personalized Medicine for ACE Inhibitors: can the Response to ACE Inhibition be Predicted on the Basis of Plasma Renin or ACE?

Cardiovascular drugs and therapy, 2014-08, Vol.28 (4), p.335-345

2014

Volltextzugriff (PDF)

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6k pathway

Cardiovascular drugs and therapy, 2007-08, Vol.21 (4), p.253-256

2007

Volltextzugriff (PDF)

Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension

Cardiovascular drugs and therapy, 2012-12, Vol.26 (6), p.511-519

2012

Volltextzugriff (PDF)

Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats

Cardiovascular drugs and therapy, 2000-10, Vol.14 (5), p.533-542

2000

Volltextzugriff (PDF)

Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence

Cardiovascular drugs and therapy, 2009-02, Vol.23 (1), p.85-92

2009

Volltextzugriff (PDF)

Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity

Cardiovascular drugs and therapy, 2012-06, Vol.26 (3), p.205-216

2012

Volltextzugriff (PDF)

Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis : In Vitro and In Vivo Studies

Cardiovascular drugs and therapy, 2007-12, Vol.21 (6), p.423-429

2007

Volltextzugriff (PDF)

Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus

Cardiovascular drugs and therapy, 2009-02, Vol.23 (1), p.17-24

2009

Volltextzugriff (PDF)

Pathophysiologic and therapeutic importance of tissue ACE: A consensus report

Cardiovascular drugs and therapy, 2002-03, Vol.16 (2), p.149-160

2002

Volltextzugriff (PDF)

It is Time to Reconsider the Cardiovascular Protection Afforded by RAAS Blockade - Overview of RAAS Systems

Cardiovascular drugs and therapy, 2013-04, Vol.27 (2), p.133-138

2013

Volltextzugriff (PDF)

Role of the Renin-Angiotensin System in Cardiovascular Disease

Cardiovascular drugs and therapy, 2010-08, Vol.24 (4), p.341-344

Cohn, Jay N.

2010

Volltextzugriff (PDF)

Is Vascular Stiffness a Target for Therapy?

Cardiovascular drugs and therapy, 2010-08, Vol.24 (4), p.305-310

Duprez, Daniel A.

2010

Volltextzugriff (PDF)

Rethinking the renin-angiotensin system and its role in cardiovascular regulation

Cardiovascular drugs and therapy, 2005, Vol.19 (1), p.77-87

2005

Volltextzugriff (PDF)

Reducing the Burden of Ischemia Reperfusion: Editorial to: “Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity” by G. Maarman et al

Cardiovascular drugs and therapy, 2012-06, Vol.26 (3), p.193-194

Beadle, Roger M.

2012

Volltextzugriff (PDF)

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

Cardiovascular drugs and therapy, 2009-04, Vol.23 (2), p.171-181

2009

Volltextzugriff (PDF)

Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease

Cardiovascular drugs and therapy, 2006-12, Vol.20 (6), p.433-439

2006

Volltextzugriff (PDF)

Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?

Cardiovascular drugs and therapy, 2009-04, Vol.23 (2), p.161-170

2009

Volltextzugriff (PDF)

Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction

Cardiovascular drugs and therapy, 2005-12, Vol.19 (6), p.383-390

2005

Volltextzugriff (PDF)

A Nonpeptide, Piperidine Renin Inhibitor Provides Renal and Cardiac Protection in Double-Transgenic Mice Expressing Human Renin and Angiotensinogen Genes

Cardiovascular drugs and therapy, 2008-12, Vol.22 (6), p.469-478

2008

Volltextzugriff (PDF)

Elastic properties and windkessel function of the human aorta

Cardiovascular drugs and therapy, 1995-02, Vol.9 (1), p.73-83

BELZ, G. G

1995

Volltextzugriff (PDF)

1 – 25 von 277

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Journals - AutoHoldings

Zeitschrift / SerieCardiovascular Drugs And Therapy

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)

Publikationsform

Artikel
(277)

Sprache

Englisch
(277)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(260)
Cardiovascular System & Cardiology
(260)
Life Sciences & Biomedicine
(260)
Pharmacology & Pharmacy
(260)
Science & Technology
(260)
Humans
(199)
Biological And Medical Sciences
(185)
Medical Sciences
(183)
Pharmacology. Drug Treatments
(171)
Cardiovascular System
(162)
Angiotensin-Converting Enzyme Inhibitors - Therapeutic Use
(150)
Male
(110)
Animals
(99)
Female
(77)
Cardiology
(72)
Medicine
(72)
Medicine & Public Health
(72)
Angiotensin-Converting Enzyme Inhibitors - Pharmacology
(69)
Middle Aged
(60)
Heart Failure - Drug Therapy
(52)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(277)
Journals@Ovid
(277)
MEDLINE
(265)
IngentaConnect Journals
(11)

Zeitschrift / Serie

Cardiovasc Drugs Ther
(3)
Cardiovasc Drug Ther
(1)

Menü

Weitere Dienste

Einstellungen

Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials

Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture

Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease

Renin-Angiotensin System Phenotyping as a Guidance Toward Personalized Medicine for ACE Inhibitors: can the Response to ACE Inhibition be Predicted on the Basis of Plasma Renin or ACE?

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6k pathway

Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension

Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats

Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence

Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity

Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis : In Vitro and In Vivo Studies

Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus

Pathophysiologic and therapeutic importance of tissue ACE: A consensus report

It is Time to Reconsider the Cardiovascular Protection Afforded by RAAS Blockade - Overview of RAAS Systems

Role of the Renin-Angiotensin System in Cardiovascular Disease

Is Vascular Stiffness a Target for Therapy?

Rethinking the renin-angiotensin system and its role in cardiovascular regulation

Reducing the Burden of Ischemia Reperfusion: Editorial to: “Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity” by G. Maarman et al

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease

Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?

Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction

A Nonpeptide, Piperidine Renin Inhibitor Provides Renal and Cardiac Protection in Double-Transgenic Mice Expressing Human Renin and Angiotensinogen Genes

Elastic properties and windkessel function of the human aorta

Aktive Filter

Suchergebnisse filtern